Results 141 to 150 of about 3,323,629 (269)
Sexual function after prostate cancer surgery or radiotherapy in an international registry
Objectives Our objective was to evaluate patient‐reported sexual function (SF) outcomes and sexual aid use 12 months after curative treatment for prostate cancer (PC). Patients & Methods This prospective registry‐based cohort study analysed men with localized or locally advanced PC enrolled in the TrueNTH Global Registry.
Y. Hess‐Busch +10 more
wiley +1 more source
Musculoskeletal health in prostate cancer patients treated with androgen deprivation therapy: a review of current practice ...
Trish Livingston (13098306) +3 more
core
The PART randomised trial protocol: Partial Ablation versus Radical Treatment for prostate cancer
Objectives Primary objective: to determine whether prostate gland partial ablation (PA) has non‐inferior oncological treatment success vs radical treatment (RT) of localised intermediate‐risk prostate cancer (irPCa). Secondary objectives: to compare (i) participant‐reported urinary and sexual dysfunction side effects, (ii) short/medium term serious ...
Richard J. Bryant +42 more
wiley +1 more source
UPDATE ON ANDROGEN DEPRIVATION THERAPY AND ADJUVANT METFORMIN (ADMET) TRIAL FOR MEN WITH TREATMENT NAIVE METASTATIC PROSTATE ...
J Gunter (13754467) +8 more
core
ABSTRACT Introduction Transgender and gender diverse (TGD) people continue to experience inequities in access to gender‐affirming care, including stigmatisation, delayed treatment and non‐inclusive healthcare encounters. Community pharmacies may represent an accessible setting to support inclusive and affirming care; however, lived experiences of ...
Jessica McCann +5 more
wiley +1 more source
Can a single element help address the multifactorial nature of ALS? Boron‐containing compounds combine responsiveness to reactive oxygen species (ROS), neuroprotective activity, and favorable pharmacological properties, offering a distinctive framework for disease modification in a complex disease like ALS.
Nitesh Sanghai +5 more
wiley +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source
Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: A systematic ...
Trish Livingston (13098306) +2 more
core
We show that emergence of castration‐resistant prostate (CRPC) is associated with significant upregulation of cyclins that positively regulate cyclin‐dependent kinase 2 (CDK2) and concomitant downregulation of CDK4 cyclins. This renders CRPC cells dependent on the high activity of CDK2, and CDK2 inhibitors synergistically sensitize CRPC cells to both ...
Joyeeta Chatterjee +3 more
wiley +1 more source

